Physiological Microenvironmental Conditions in Different Scalable Culture Systems for Pluripotent Stem Cell Expansion and Differentiation

Fuad G. Torizal1, *, Ikki Horiguchi2, Yasuyuki Sakai2, 3
1 Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan
2 Department of Chemical Systems Engineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan
3 International Research Center on Integrative Biomedical Systems CIBiS, Institute of Industrial Science, The University of Tokyo, Tokyo, Japan

Article Metrics

CrossRef Citations:
Total Statistics:

Full-Text HTML Views: 157
Abstract HTML Views: 83
PDF Downloads: 70
ePub Downloads: 66
Total Views/Downloads: 376
Unique Statistics:

Full-Text HTML Views: 117
Abstract HTML Views: 63
PDF Downloads: 50
ePub Downloads: 46
Total Views/Downloads: 276

© 2019 Torizal et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the Department of Bioengineering, Graduate School of Engineering, The University of Tokyo, Tokyo, Japan. The University of Tokyo, 7-3-1, Hongo, Bunkyo-Ku, Tokyo, Japan; Tel: +81-3-5841-7032; Fax: +81-3-5841-7032; E-mail:


Human Pluripotent Stem Cells (PSCs) are a valuable cell type that has a wide range of biomedical applications because they can differentiate into many types of adult somatic cell. Numerous studies have examined the clinical applications of PSCs. However, several factors such as bioreactor design, mechanical stress, and the physiological environment have not been optimized. These factors can significantly alter the pluripotency and proliferation properties of the cells, which are important for the mass production of PSCs. Nutritional mass transfer and oxygen transfer must be effectively maintained to obtain a high yield. Various culture systems are currently available for optimum cell propagation by maintaining the physiological conditions necessary for cell cultivation. Each type of culture system using a different configuration with various advantages and disadvantages affecting the mechanical conditions in the bioreactor, such as shear stress. These factors make it difficult to preserve the cellular viability and pluripotency of PSCs. Additional limitations of the culture system for PSCs must also be identified and overcome to maintain the culture conditions and enable large-scale expansion and differentiation of PSCs. This review describes the different physiological conditions in the various culture systems and recent developments in culture technology for PSC expansion and differentiation.

Keywords: Pluripotent stem cells, Culture systems, Mechanical stress, Microenvironmental condition, Mass production, Bioreactor.


Human Pluripotent Stem Cells (PSCs) exhibits decent self-renewal and differentiation capability into various cell types consisted of the human body. They show remarkable promise for clinical applications and novel strategies in regenerative medicine, drug discovery, and in vitro toxicology for clinical and industrial purposes. The target organs of these technologies vary widely from small organs such as retinal tissue [1] to large organs such as the heart [2], pancreas [3], and liver [4].

For all of these applications, a sufficient quality and quantity of PSCs are needed, which can be generated in scalable three dimensional (3D) culture system that supports a larger density of cell culture and higher growth rate with good manufacturing practice-compatible, simple, and easy to automate [5-8]. Although numerous research groups have attempted to develop optimum culture systems for PSCs, the currently available culture systems show some limitations, such as difficulties in scaling up, automation, and standardization. Therefore, the effectiveness of these scalable culture technology for PSC expansion and differentiation must be improved.

Here, we introduce the advantages and remaining disadvantages of various culture systems for PSCs mass production and differentiation. In addition, we describe the important microenvironmental conditions required to optimize PSCs mass production systems development as a consideration when selecting, combining, or modifying various culture systems.


Generally, PSCs can be derived from embryonic or adult tissue and are classified as Embryonic Stem Cells (ESCs) or induced Pluripotent Stem Cells (iPSCs), respectively.

ESCs were firstly isolated from the inner cell mass of blastocysts by Thomson et al. in 1998 [9]. ESCs have some disadvantages, such as the requirement to extract and manipulate the embryo, which is limited by ethical considerations. In clinical use, because ESCs are derived from embryonic stage cells, it is more difficult to obtain immunocompatible cells for transplantation. This increases the risk of immune rejection in allogeneic transplantation. To overcome this limitation, immunosuppression or immuno-isolation such as encapsulation is necessary when ESCs are administered into a recipient’s body. These techniques have been applied in some clinical trials, such as to encapsulate insulin-producing cells from human ESCs during pancreatic regeneration [10].

iPSCs were firstly generated by Yamanaka et al. in 2006 [11, 12]. Adult somatic cells were reprogrammed into pluripotent cells by overexpressing transcription factors Oct4, Sox2, Klf- 4 and c-Myc via transfection into human fibroblasts [13-14]. This achievement is very promising for both regenerative medicine and industrial-related applications such as drug screening. iPSCs not only show similar characteristics such as remarkable pluripotency to ESCs but also present minimum ethical issues such as those involving embryo destruction for ESCs [5, 15, 16]. Moreover, this technology provides the opportunity to generate iPSCs from patients via tissue biopsy, which may minimize immune rejection by using autologous transplantation. In contrast, this reprogramming technology also has drawbacks. The integration of the transcription factor into cells genome can cause an unwanted effect. For instance, the insertion of proto-oncogene like c-myc increases the risk of tumor formation [17]. Currently, numerous studies were attempted to resolve this problem with non-integrating methods [17-25]. However, most of the results show a lack of reprogramming efficiency when compared to integrating methods.


The first method for the large-scale production of animal cells was developed for baby hamster kidney cells by Capstick et al. in 1962 [26, 27]. This technology has been applied to a broad range of biological products, such as monoclonal antibodies, hormones, vaccines, and other pharmaceutical products [28]. In PSC cultivation, the purpose of mass production is to prepare a large number of cells for industrial and clinical use. For example, pancreatic islet transplantation requires at least 6 × 108 beta cells which derived from an approximately 0.6 m2 of culture area; this corresponds to 600 6-well plates [29]. To regenerate 30% of liver tissue, 6 × 1010 liver cells are required, covering 60 m2 of culture area or 60,000 6-well plates [30]. To obtain the high-quality cells for these applications, it is important to sustain the self-renewal properties, maintain the pluripotency, and provide cryopreservation to maintain established cultures by using proper microenvironment for cell growth [31].

Selection of the culture system for PSCs largely depends on their cellular characteristic during cultivation (Table 1). In all culture methods, a single hPSC is known to undergo apoptosis without Rho-associated protein kinase (ROCK) inhibition. These conditions are thought to be caused by anoikis, the apoptosis mechanism induced by a lack or alteration of cell-cell or cell-matrix interactions [32]. When hPSCs dissociated into single cells, the loss of E-cadherin, a key molecule in intercellular adhesion, can activate the ROCK-dependent signaling cascade to induce myosin hyperactivation. These cascades can increase myosin contraction, impacting cellular vulnerability and causing apoptosis [33-35]. Thus, hPSCs are typically seeded as clusters or single cells with ROCK inhibitors such as Y-27632 and HA-1077 [36, 37]. Adherent culture is the most widely used method for culturing undifferentiated PSCs. However, they can also be cultured in suspension as single cells or aggregates [38].

The extracellular signaling is also important to maintain the state of pluripotency. Several study revealed several signaling molecule such as Transforming Growth Factor beta 1 (TGF-β1) [39, 40], activin A [39, 41, 42], bone morphogenetic protein 4 (BMP-4) [43, 44], Fibroblast Growth Factor 2 (FGF2) [45], Leukemia Inhibitory Factor (LIF) [43], and Nodal [39, 46]. In order to provide the required amount to keep their self-renewal, these molecules were regularly supplemented in the culture medium.

Table 1. Possible combined culture techniques in various PSCs culture systems.
PSCs Type Possible Combined Culture Technique
Adherent Static Culture Systems Automation
Hollow fiber bioreactor Scaffold
Stirred culture systems Microcarrier
Cell encapsulation
Rotary culture systems Microcarrier
Cell encapsulation
Suspension Stirred culture systems Aggregates culture
Cell encapsulation
Rotary culture systems Aggregates culture
Cell encapsulation

3.1. Adherent Culture Methods

Adherent culture is the most widely used cell culture method for biological studies. For adherent PSCs, the interactions between PSCs and feeder cells are essentially required to provide support, such as producing secreted growth factor, expressing specific ligands, releasing cytokine, and providing the cell-cell interaction for stable attachment which is important for the cell growth and pluripotency [47, 48]. Several proteins which required for maintaining the pluripotency, such as Transforming Growth Factor beta 1 (TGF-β1) [49], activin A [49], bone morphogenetic protein (BMP)-4 [49], Fibroblast growth factor 2 (FGF2) [49], and Wnt-3 [50] were secreted by the feeder cells.

Inactivated mouse embryonic fibroblasts are traditionally used as a supportive feeder layer to sustain hPSC propagation [15, 51, 52]. However, co-culturing PSCs with animal feeder cells present the transmission of unwanted genes, viral contaminations, or immunogenic nonhuman saccharides such as sialic acid [53], as well as variability in experimental results [54]. To overcome these limitations, many studies have developed xeno-free human feeder cells, such as human foreskin fibroblasts [49, 55, 56] human adipose-derived stromal cells [57, 58], amniotic epithelial cells [59, 60], fetal skin cells [61, 62], and amniotic Mesenchymal Stem Cells (MSCs) [63]. Autologous adult human fibroblasts are preferably used as feeder cells in clinical applications because they minimize xenogeneic substances from animals and are easy to obtain. Moreover, human PSCs can be generated from isogenic parental cells as feeder cells, and thus the compatibility of cell-cell interactions can be better maintained [64]. However, maintenance in the culture systems using feeder cells is costly and time-consuming.

Therefore, in large-scale culture, the application of feeder layer can be eliminated to obtain a higher yield and reduce production costs [65]. Alternatively, feeder cells can be replaced with a conditioned medium and Extracellular Matrix (ECM), such as Matrigel [66], fibronectin [66], laminin [67-69], and vitronectin [70], which are normally produced by feeder cells to maintain the PSCs in culture. The medium consists of non-xenogeneic compounds that are also essentially required for the propagation and differentiation of hPSCs used in clinical applications. In addition, the growth factor such as such as activin A, TGF-β1, FGF2, Insulin, Transferrin, and Nodal also added in the medium formulation to support the proliferation and reconstitute its production from the feeder cells [70]. Currently, feeder cell-conditioned media or commercially available synthetic media for feeder-free culture have been used for PSCs culture. Media selection varies depending on the cell type and it is necessary to optimize the media conditions for different culture methods and cells [7, 71, 72].

To harvest PSCs, the conventional adherent method requires cell removal by mechanical or enzymatic separation, which may damage the cells and affect the quality and quantity of mass-produced PSCs [73]. These conditions make the use of human PSCs for clinical applications which were more difficult to achieve.

3.2. Suspension Culture Methods

Current development in cell culture technology has enabled adherent PSCs to be adapted for suspension culture. This method can provide a better mass transfer of nutrition and does not require enzymatic or physical removal, which can disrupt the cell membrane. Elimination of the feeder layer and synthetic matrices can simplify the procedure and minimize contamination. In industrial applications, this system can also increase the scalability by enabling high-density cell culture (> 1 × 107 cells/mL) and significantly reducing the costs involved [28]. A recent experimental study revealed that global gene expression, mainly the pluripotency gene and functional characteristics, were comparable to those maintained under adherence conditions [74, 75]. Differentially expressed genes between suspension and adherent PSCs culture were mainly associated with cellular adhesion and extracellular matrix interactions [74, 76]. In addition, the 3D structure also shows better performance in differentiation in comparison with adherent culture based-differentiation. This phenomenon occurred because of the lack of interaction between PSCs in adherent culture [77].


The bioreactor system provides expandable culture volume and dynamic physiological environment compared to conventional dish culture [78]. Ideally, bioreactor systems for PSC cultivation should meet several essential requirements, such as efficient mass transfer of oxygen and nutrients, waste transfer, and minimum shear stress [79]. These microenvironmental factors may affect cell pluripotency and fate during differentiation. Depending on the utilization, optimal PSCs expansion or differentiation can be conducted under various conditions (Table 2).

Generally, in the culture systems, PSCs are incubated at 37°C and pH 7.4. The instability of these culture conditions can inhibit cell proliferation, reduce pluripotency, and decrease cell viability [80, 81]. One of the main limiting factors in PSCs culture is the low pH which is mostly caused by the accumulation of secreted lactate in culture medium [45, 82, 83]. This condition occurred because of it`s higher glycolysis rate and cell cycle profile when compared to adult somatic cells, impacted to higher lactate secretion than glucose consumption [82, 84]. Therefore, the continuous removal of lactate is necessarily required in PSCs culture system.

Viscosity is correlated with fluid movement in culture systems. Appropriate medium viscosity properties are required to maintain the proper PSCs culture. Medium with lower viscosity exhibits more rapid mass transfer and uniform conditions in mass production. In contrast, a previous study showed that human PSCs culture in less viscous media may cause cell agglomeration and shear-induced apoptosis, leading to lower yields [8]. In addition, a recent study showed that the culture medium which exhibit continuous viscoelasticity by using an optimized non-toxic polymer, such as low acyl gellan gum can form large numbers of uniformly sized aggregates and maintain cells in a suspension without agitation, is one promising culture strategy [85]. However, scaling up of this method results in the limited mass transfer of oxygen and nutrients.

Table 2. Comparison and example of various culture systems application for PSCs expansion and differentiation. The (*) mark showing the remaining disadvantage which need to be overcome.
Culture Systems Ease of Scale Up Ease of Monitoring Ease of Harvesting Mass Transfer Shear Stress References of Application in PSCs Expansion References of Application in PSCs Differentiation Types
General culture systems Conventional static culture low* low* high low* low hiPSCs[52,148,149], hESCs[52], miPSCs[150], mESCs[151] Hepatocyte [152], chondrocytes [153],
muscle fiber cells [154],
lung and thyroid progenitor cells [155],
odontoblast [156], cardiomyocytes [157]
Automation medium high high low* low hiPSCs [106,110,158-160],
hESCs [161], mESCs [160], miPSCs [162]
Cardiomyocyte [159],
neural cells [160]
Stirred bioreactor high high high high high* hiPSCs [97,113,114,148,163,164], hESCs [97,114], miPSCs [165] Hepatocyte [123], cardiomyocytes [122,166,167], pancreatic β cells [168],
Endothelial cells [169]
Rotary bottle medium medium high high medium mESCs [170], hESCs [171] Cardiomyocyte [127][166], osteogenic cells [170]
Hollow fiber bioreactor medium low* low* medium low mESCs [172], hESCs [131] Hepatocyte [129,130,173]
Other culture techniques Microcarrier high low* low* medium high* mESCs [174], hESCs [175],
hiPSCs [175]
Neural progenitor [176], endoderm progeny [177], hematopoetic cells [178], hepatocytes [179], cardiomyocytes [168,180,181].
Cell encapsulation medium low* low* medium low miPSCs [145], mESCs [142,146], hESCs [141,182] Cardiomyocyte [143], pancreatic cells [183],
definitive endoderm [182], osteogenic cells [170]

Oxygen is one of the most important components in cell culture systems and it is involved in nearly all cellular aerobic metabolic cycles. In PSCs propagation, the concentration of oxygen in the culture media is a crucial factor in pluripotency and proliferation that maintains their cellular characteristics [86]. An in vitro study clearly demonstrated that differentiation was significantly reduced in human ESCs under hypoxic culture conditions (1-5% O2) compared to its culture under normoxic conditions (21% O2) by morphologically distinct growth area examination and expression of pluripotency markers according to biochemical and immunohistology assays [84, 87]. Another study showed that hypoxia of iPSCs cultivated under 5% O2 improved the efficiency of iPSC proliferation and enhanced the expression levels of transcription factors for iPSC reprogramming (Oct3/4 and Nanog), which are required to maintain pluripotency [88]. Repeated passaging of hESCs under normoxic culture conditions resulted in an increased number of differentiated cells and reduced self-renewal [89]. ESC growth under hypoxic conditions can preserve the pluripotency during repeated passaging and able to promote the formation of embryoid bodies after random differentiation [87]. Forsyth et al. reported that physiologic oxygen (2%) may reduce chromosomal damage and induce recovery after oxidative damage post room oxygen (20%) treatment [90]. These studies clearly showed that oxygen concentration affects PSC growth, differentiation, and EB formation. In this regards, the PSCs can be maintained or expanded in hypoxia condition and it can gradually switch into normoxia condition in a certain stage when the differentiation was performed. For example, the different oxygen concentration can be applied in hepatic differentiation by mimicking the original liver development during embryogenesis [91]

Cell aggregation control is very important for maintaining PSCs in an undifferentiated state and preserving cellular viability. In suspension hPSC propagation in vitro, cell-cell interactions are essentially required. Therefore, PSCs must grow in appropriate-sized aggregates. A recent study demonstrated that excess aggregation can direct PSCs into spontaneous differentiation, which occurred as the size of PSCs aggregates increased [92-95]. Moreover, insufficient oxygen and nutrition exposure can result in necrotic cells in the center of the aggregates [96]. Some approaches for controlling aggregation in suspension culture have been reported. Culturing in a microwell is one of the most widely used technologies for controlling aggregation. Seeded cells are divided and form a single aggregate in each microwell, resulting in the reproducible growth of uniform aggregates with high efficiency. However, the culture operations are still difficult to control because the high medium flow can be resulted from strong flow during culture medium changes, causing aggregates to detach from the microwell and fused each other. Therefore, it is technically required gentle treatment during medium removal or addition. Alternatively, to control these aggregations in suspension culture, dynamic conditions can be applied in the bioreactor system by adding impeller agitation of the culture media, but as an adverse effect, excessively high shear stress causes cell death and spontaneous differentiation [97, 98]. One of recently developed method for controlling aggregation is the addition of lipid-rich albumins, such as Albumax. This compound can reduce aggregation by inhibiting E-cadherin-mediated cell-cell attachment. A previous study showed that 0.2-0.5% Albumaxin the culture medium is the optimal concentration for obtaining appropriately sized aggregates and higher hiPSC yields in 12-well plates in well-preserved pluripotency [99].

Shear stress is a particularly important biomechanical factor in mammalian cell culture. Most of the cell types respond to shear stress by physiological or gene expression alterations [100, 101]. Generally, excess hydrodynamic stress by vigorous agitation can decrease the viability of mammalian cells [76, 102]. In addition, excess agitation during cultivation may affect the phenotype and characteristics of PSCs. For example, an excessive centrifugal force of 1000 ×g or more may induce phenotypical shifting and decrease the proliferation rate during expansion [80]. A study conducted by Sargent et al. revealed that exposure to hydrodynamic stress conditions not only significantly affected aggregates formation and structure, but also induced downregulation of pluripotency genes, resulting in spontaneous differentiation [103]. Moreover, in the suspension culture systems, cells in aggregates are exposed to higher shear stress than individual cells because of their large particle diameter [104].

Fig. (1). Different culture systems in PSCs cultivation: 2D static culture (A), solid filled-microcarrier (B), porous microcarrier (C), coated microcarrier (D), cell encapsulation (E), stirred bioreactor (modified by oxygen sparger and perfusion systems) (F), hollow fiber systems (G), and rotary culture systems (H).


5.1. PSC Adhesion Culture Systems

Conventionally, PSCs are cultured in tissue culture dishes (Fig. 1A), multiwell plates, and tissue culture flasks. These methods provide two-dimensional surfaces for the growth of PSCs. Under these two-dimensional conditions, morphological examination of PSCs in colonies or as single cells can be more easily observed by direct visualization using a microscope, which is important for monitoring both undifferentiated PSCs or changes in PSC shape during various stages of differentiation. These disposable systems are also relatively simple, easy to handle, and inexpensive. However, in large-scale PSC production, this system represents several disadvantages, such as a limited surface area (approximately 2-225 cm2 working area), which is required for adherent cells. This condition makes the scaling up difficult. Furthermore, the static conditions of the culture can cause poor mixing of the medium, leading to concentration gradients in PSCs culture [38]. Because of these gradients, controlling parameters such as temperature, pH, and dissolved O2 is challenging in adhesion culture systems. Multiple plates or flasks (or flasks with multiple trays) are required to obtain large numbers of cells simultaneously, but these vessels also require repeated extensive handling for feeding and subculturing, making the process more laborious and prone to contamination [105]. In addition, the considerable amount of these disposable plastic materials waste can cause an environmental problem.

To overcome the difficulty of handling, an automated culture system has been developed by utilizing a machine, robotics, and programming to conduct cell propagation. Automation systems show many benefits, such as the ability to significantly reduce the working time for the technician, provide automated and scheduled screening, imaging, or cell maintenance based on cell growth, and minimize the risk of contamination [106, 107]. Most of the commercially available automated culture systems, such as Cytogration™ systems, SelecT™ systems, and AcCelerator™ systems, are based on continuous cell maintenance, which automatically delivers media containing nutrients and removes cellular waste products [108]. They also allow for periodic automated evaluation, such as to detect the pH, nutrition and waste concentrations, cell growth rate, and cellular viability [109]. These systems provide more consistent data regarding the culture procedure [109]. Soares et al. established a protocol for maintaining hiPSCs using feeder-free and chemically defined media on the inCompacTSelecT™ automation platform without significantly decreasing pluripotent capabilities [110]. Current automated culture technology, such as CellCelector also equipped with cell sorting combined with a cell scrapping module to selectively harvest the PSCs colony from feeder cells [111].

5.2. PSC Suspension Culture Systems

5.2.1. Stirred Bioreactor

A stirred bioreactor is one of the most common types of bioreactor systems used to cultivate PSCs on a large scale. This culture system provides a homogeneous environment for the expansion of ESCs and iPSCs by continuous agitation in large working volumes (50 mL-200 L) [5, 112, 113] (Fig. 1F). Various types of feeding operations such as batch, fed-batch, or perfusion have been developed. In these culture systems, PSCs are cultured as aggregates or adherent colonies combined with various 3D cell culture technology, such as microcarrier, cell encapsulation, or scaffold. The combination of culture techniques may enhance scalability, improve oxygen and mass transfer, and ease complicated handling. In addition, this bioreactor is controllable by installing sensors to detect pH, dissolved O2, medium level, and temperature [114].

The stirred bioreactor mainly using an agitation mechanism with an impeller or stirrer to obtain a uniform culture mixture. In suspension culture, this agitation is important for maintaining pluripotency. A previous study evaluated various levels of shear in a stirred suspension bioreactor to determine its ability to maintain aggregate size. The results showed that the higher level of shear force in the suspension bioreactor produced smaller hESC and hiPSC aggregates compared to lower shear force [114]. On the other hand, excessive mechanical agitation can produce high shear stress, which can harm PSCs by affecting their pluripotency and viability [114-117]. Such damage can be relieved by decreasing the rotational speed, modifying the shape and size of the impeller, or by adding additional substances, such as bovine serum albumin, to protect the cells from shear stress.

In some bioreactors, installation of a gas sparger can accelerate gas transfer and increase hydrodynamic movement. However, the bubbles produced by the gas sparger may potentially harm the cells. These bubbles rise faster than the medium flow and slowly carry the cells to the surface, increasing the shear stress to the cell membrane [118]. This condition was previously demonstrated by microfluidic assessment, which mimics bubble-induced shear stress, in Chinese hamster ovary cells [119]. In addition, bubble accumulation can form a foam, causing bubble burst-associated damage at the medium surface [120]. In most cases of mammalian cell culture, small bubbles (approximately <2 mm in diameter) are more significantly damaging to cells than large bubbles (10–20 mm). Agitation by an impeller can also enhance cell membrane damage by disrupting the large gas bubbles arising from the sparger [121].

Stirred bioreactor also can be applied in PSC differentiation. Although one study demonstrated its capability to support the high-scale differentiation of PSCs such as cardiomyocytes from murine ESCs [122] and hepatocytes from hiPSCs [123], the hydrodynamic conditions in this bioreactor appear to produce a high subpopulation of cells with heterogeneous phenotypes of various types of cells [123, 124].

5.2.2. Rotary Bottle Culture Systems

Rotating bottle culture systems enhance the efficiency of aggregate formation, increase cell yield and homogeneity, and do not adversely affect differentiation [103]. This culture system was first developed by NASA to investigate cell culture systems in the space. Rotary culture systems consist of rotating 3D chambers to accommodate the cell culture, which is suspended under microgravity conditions, creating a continuous homogenous environment with low shear stress for PSCs culture (Fig. 1H). These hydrodynamic properties are very important for supporting the maintenance of aggregate formation in suspension culture. This system improves the homogeneous condition and prevents excess PSCsagglomeration [103, 125]. In large-scale production of PSCs, their systems complexity causes difficulties in continuous feeding and uses a low working volume (approximately 10–500 mL) [112].

Several studies have demonstrated that the dynamic rotary suspension culture enhances PSCs aggregation and differentiation by supporting specific signaling pathways involved in directing cell fate. Lei et al. found that the biomechanical properties of this culture system induce Wnt/β-catenin signaling, which is responsible for mouse ESC differentiation into the mesoderm and endoderm [126]. Another study revealed that the cardiogenic differentiation of murine ESC aggregates in a rotary culture environment can produce a higher percentage of contracting cardiomyocytes compared to differentiation in adherent culture [127].

5.2.3. Hollow Fiber Bioreactor

The hollow fiber bioreactor is a culture system based on a perfusion system that uses small semi-permeable membrane hollowed fiber tubes. By circulating the culture medium, this system can provide an exchange between small molecule components, such as nutrients and metabolic wastes (Fig. 1G). This system mimics the microenvironment of blood vessels in vivo by using two different compartments. The first compartment is an intercapillary space within the hollow fibers, while the second is extra-capillary space surrounding the hollow fibers [79]. The cells are cultured in the extra-capillary space, and oxygenated medium at an appropriate pH is circulated through hundreds to thousands of capillaries within the hollow-fiber cartridge using perfusion systems. Oxygenation and pH control is achieved by a gas-permeable surface in a CO2 incubator. The exchange of nutrients and waste products is achieved by diffusion through the semi-permeable membrane fibers. A separate culture compartment and perfusion compartment produces the low-stress environment required for maintaining PSC pluripotency and viability. In this system, the culture compartment can be filled with up to 108 cells/mL (near the tissue density in vivo) [128]. Therefore, this system requires less medium and fewer growth factors than traditional culture methods. This high-density culture also can facilitate the three-dimensional growth resembling the in vivo tissue structure to support PSC differentiation. Recent studies showed that the functional activity and formation of several tissue-like structures were increased in hepatocyte-derived hiPSC aggre-gates after hepatic differentiation using this system [129, 130].

However, hollow fiber systems have some disadvantages, such as difficulties in monitoring and controls. At high cell densities, spatial concentration gradients in the extra-capillary compartment can form, based on the distance of the PSCs to the intercapillary compartment. Previously, a study by Roberts et al. evaluated the potential and feasibility of using hollow fiber systems for hESC mass production. The results indicated that hESCs can be scaled up in a hollow fiber bioreactor without a significant decrease in pluripotency [131].


6.1. Microcarriers

In optimizing the scalable culture systems for expanding undifferentiated PSC culture, traditional adherent cell culture can be utilized on polymer- or hydrogel-based microcarrier beads [132]. Microcarriers can provide a high surface area for cell attachment and proliferation. This technique enables adherent-type cells to be treated as similar to the suspension culture. Compared to conventional static adherent culture, the main advantage of microcarriers is that they can accommodate a larger number of cells and occupy less space in the bioreactor [133]. According to a previous study, culturing on microcarriers was conducted using 2- to 4-fold higher densities of iPSCs than in conventional adherent culture [134].

Generally, microcarriers are divided into two types: nonporous microcarriers and porous microcarriers (Fig. 1B, 1C). Solid-filled microspheres or nonporous microcarriers are composed of bioceramic or biopolymers. Anchorage-dependent animal cells can be grown on the surface of small-diameter spheres that can be maintained similarly to in suspension cultures. Equal effects of nutrients and growth on the surface of microcarriers can be achieved to expand cells with homogeneous characteristics and differentiation. However, direct contact between the attached cell and media caused some frictional and shear stress, which can damage the cells, mainly when combined with highly hydrodynamic conditions such as in a stirred bioreactor. Porous microcarriers contain pores and channels that are large enough for cells to enter and grow within the carriers, which allow for culturing at higher cell densities than for nonporous microcarriers. In addition, these microcarriers can create a microenvironment inside the beads, protecting the cells from shear and frictional stresses caused by aeration and agitation in a dynamic bioreactor. Thus, porous microcarriers are more appropriate for large-scale mass production of cells compared to nonporous microcarriers. However, it is difficult to observe cells inside the microcarriers and separating and collecting the cells is challenging. In addition, the gradients of conditions, such as different in hydrodynamic properties, cell-cell interactions, and nutrition or oxygen concentrations, have been observed in pores. Consequently, nutrient transfer and cellular waste product release will be more limited for the cells inside the pores [135], [136]. This condition also can cause variability among cultured PSCs undergoing expansion or differentiation.

Nonporous microcarriers can be coated with ECM such as collagen or fibronectin to enhance cell attachment and adhesion (Fig. 1D) [132, 137]. These coatings are completely dissolvable in trypsin solution, which allows the sampling, counting, and harvesting of the cells without interference from the carriers. Chen et al. investigated the cellular attachment efficiency, growth, and pluripotency of hESCs using 10 types of microcarriers. The study revealed that poor growth and gradual loss of pluripotency occurred at the same time because of a lack of ECM interactions in uncoated microcarriers. Higher yields and stable pluripotent states of hESCs grown using Matrigel-coated microcarriers were achieved compared to using other types of microcarrier culture [138]. A study also reported the successful differentiation of the mesoderm from hESCs and hESC using similar types of microcarriers [139].

Although cellulose is the most common material used for microcarriers, various other materials have also been used, such as hydroxyapatite, tricalcium phosphate, and glass ceramics. Synthetic degradable polymers such as polylactic acid, polyglycolic acid, and polycaprolactone are also used as microcarriers. According to a previous study, hESCs did not attach and grow on microcarriers with a negatively charged surface [65]. The sizes of the spheres are diverse depending on the conditions, such as material content, surfactant type and amount, type of solvent, and stirring speed. Synthetic polymers typically lack hydrophilic and adhesive ligands, which are required for cell attachment. Therefore, the surface requires hydrophilization and coating with adhesive proteins such as Matrigel, fibronectin, or collagen. For PSCs propagation, it has been reported that the use of combined materials in microcarriers can affect their cellular characteristics. For example, combining hydroxyapatite powder within polylactic acid can potentially improve cell adhesion, cell growth, and osteoblastic differentiation [135].

6.2. Cell Encapsulation

The main principle of cell encapsulation is to envelope viable cells or aggregates within semi-permeable membrane layers to protect the cells from shear stress and to accumulate the native products secreted from cells while exchanging nutrients and wastes (Fig. 1E) [140]. Various sizes of capsules are available for cell encapsulation, which are 0.3-1.5 mm or larger. Enclosing PSCsin hydrogel can create a microenvironment with cell-hydrogel contact and auto/paracrine effects while protecting them from the hydrodynamic shear stress. A report showed that encapsulation provided more than 6 months of prolonged feeder-free PSCs expansion in well maintained pluripotency [141]. Another report showed that the differentiation markers in encapsulated PSCs were downregulated compared to cells in conventional suspension culture, which prevented unexpected PSCs differentiation [142]. Besides for PSCs expansion, the cell encapsulation can also be utilized for differentiation. Kerscher et al. performed the cardiac differentiation of hiPSCs by using direct hydrogel encapsulation [143]. Various types of hydrogels are used for encapsulation, such as PEG [143], agarose [38], hyaluronic acid [144], and calcium alginate [145]. Calcium alginate hydrogel is the most widely used hydrogel for encapsulation because of its fast and reversible gelation. A recent investigation revealed that alginate composition can influence the cellular phenotype of murine ESCs towards the preservation of pluripotency or differentiation [146].

In contrast to these advantages, the application involves an encapsulation and decapsulation process, which is challenging when using hydrogel with non-reversible gelation. In addition, the PSCs which exhibit a high proliferation rate can escape from hydrogel capsules and break outside the capsules when it could not accommodate the cell growth. Coating capsules with a solid shell can prevent this escape but may increase the difficulties of decapsulation [145]. Thus, cell encapsulation can be utilized for long-term maintenance or implantation to achieve immuno-isolation by protecting cells from antibody recognition.

6.3. Perfusion Systems

To optimize the mass transfer of essential compounds, some bioreactors are equipped with continuous perfusion systems. This configuration provides better oxygen transport and enhance the cell feeding by frequently removing byproducts or metabolic wastes and replacing the fluids with fresh medium containing nutrients [98]. One study reported that PSCs cultivation successfully maintained with good viability, pluripotency, and genetic stability after 6 days of culture by automated perfusion feeding of mESCs in a Petri dish. This system also significantly enhanced the cellular growth rate [147].


As described above, various bioreactor systems provide different microenvironments and physiological factors. In addition, the optimum condition for PSCs depends on the stage of culture, such as maintenance, propagation, or differentiation into target cells. For example, maintenance and propagation require rapid exchange of nutrients and wastes because of the rapids anaerobic respiration in these cells. Therefore, the perfusion system or fed-batch culture system is preferred for PSCs propagation. In contrast, the culture costs for differentiation are much higher than those during maintenance because it requires numerous amount of growth factors combinations. Therefore, the use of growth factors should be reduced, such as in dialysis culture systems. Thus, choosing an appropriate culture system is important for the industrial application of PSCs.


Not applicable.


The authors declare that there is no conflict of interest, financial or otherwise.


Declared none.


[1] Iwasaki Y, Sugita S, Mandai M, et al. Differentiation/ purification protocol for retinal pigment epithelium from mouse induced pluripotent stem cells as a research tool. PLoS One 2016; 11(7): e0158282.
[2] Kempf H, Andree B, Zweigerdt R. Large-scale production of human pluripotent stem cell derived cardiomyocytes. Adv Drug Deliv Rev 2016; 96: 18-30.
[3] Rezania A, Bruin JE, Arora P, et al. Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells. Nat Biotechnol 2014; 32(11): 1121-33.
[4] Kondo Y, Iwao T, Nakamura K, et al. An efficient method for differentiation of human induced pluripotent stem cells into hepatocyte-like cells retaining drug metabolizing activity. Drug Metab Pharmacokinet 2014; 29(3): 237-43.
[5] Serra M, C. Brito PA. Bioengineering strategies for stem cell expansion and differentiation. Rev da Soc Port Bioquímica 2010; 7: 30-7.
[6] Rodrigues CAV, Fernandes TG, Diogo MM, da Silva CL, Cabral JMS. Stem cell cultivation in bioreactors. Biotechnol Adv 2011; 29(6): 815-29.
[7] Chen VC, Couture LA. Development of scalable cGMP-compliant human embryonic stem cell suspension culture system. Isct 2012; 19(5): 1-6.
[8] Lei Y, Jeong D, Xiao J, Schaffer DV. Developing defined and scalable 3D culture systems for culturing human pluripotent stem cells at high densities. Cell Mol Bioeng 2014; 7(2): 172-83.
[9] Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282(5391): 1145-7.
[10] Agulnick AD, Ambruzs DM, Moorman MA, et al. Insulin-Producing endocrine cells differentiated In Vitro from human embryonic stem cells function in macroencapsulation devices In Vivo. Stem Cells Transl Med 2015; 4(10): 1214-22.
[11] Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126(4): 663-76.
[12] Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131(5): 861-72.
[13] Villa-Diaz LG, Ross AM, Lahann J, Krebsbach PH. Concise review: The evolution of human pluripotent stem cell culture: from feeder cells to synthetic coatings. Stem Cells 2013; 31(1): 1-7.
[14] Wong SY, Soto J, Li S. Biophysical regulation of cell reprogramming. Curr Opin Chem Eng 2017; 15: 95-101.
[15] McDevitt TC, Palecek SP. Innovation in the culture and derivation of pluripotent human stem cells. Curr Opin Biotechnol 2008; 19(5): 527-33.
[16] Serra M, Brito C, Sousa MFQ, et al. Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. J Biotechnol 2010; 148(4): 208-15.
[17] Okita K, Yamanaka S. Induced pluripotent stem cells: opportunities and challenges. Philos Trans R Soc Lond B Biol Sci 2011; 366(1575): 2198-207.
[18] Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science (80-) 2008; 322(5903): 949-53.
[19] Ma T, Xie M, Laurent T, Ding S. Progress in the reprogramming of somatic cells. Circ Res 2013; 112(3): 562-74.
[20] Hanna JH, Saha K, Jaenisch R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 2010; 143(4): 508-25.
[21] Brouwer M, Zhou H, Nadif Kasri N. Choices for induction of pluripotency: Recent developments in human induced pluripotent stem cell reprogramming strategies. Stem Cell Rev 2016; 12(1): 54-72.
[22] Eguchi T, Kuboki T. Cellular reprogramming using defined factors and microRNAs. Stem Cells Int 2016; 2016
[23] Deng X-Y, Wang H, Wang T, et al. Non-viral methods for generating integration-free, induced pluripotent stem cells. Curr Stem Cell Res Ther 2015; 10(2): 153-8.
[24] Schlaeger TM, Daheron L, Brickler TR, et al. A comparison of non-integrating reprogramming methods. Nat Biotechnol 2015; 33(1): 58-63.
[25] Zhou YY, Zeng F. Integration-free methods for generating induced pluripotent stem cells. Genomics Proteomics Bioinf 2013; 11(5): 284-7.
[26] Bangham AD, Horne RW, Glauert AM, Dingle JT, Lucy JA. Action of saponin on biological cell membranes. Nature 1962; 196: 952-5.
[27] Li W, Han Y, Yang H, Wang G, Lan R, Wang JY. Preparation of microcarriers based on zein and their application in cell culture. Mater Sci Eng C 2016; 58: 863-9.
[28] Wang D, Liu W, Han B, Xu R. The bioreactor: a powerful tool for large-scale culture of animal cells. Curr Pharm Biotechnol 2005; 6(5): 397-403.
[29] Zweigerdt R. Large scale production of stem cells and their derivatives. Adv Biochem Eng Biotechnol 2015; 2009(123): 127-41.
[30] Bianconi E, Piovesan A, Facchin F, et al. An estimation of the number of cells in the human body. Ann Hum Biol 2013; 40(6): 463-71.
[31] Lavon N, Zimerman M, Itskovitz-Eldor J. Scalable expansion of pluripotent stem cells. Adv Biochem Eng Biotechnol 2018; 163: 23-37.
[32] Frisch SM, Screaton RA. Anoikis mechanisms. Curr Opin Cell Biol 2001; 13(5): 555-62.
[33] Chen G, Hou Z, Gulbranson D, Thomson JA. Actin-myosin contractility is responsible for the reduced viability of dissociated human embryonic stem cells. Cell Stem Cell 2012; 313(1): 178-91.
[34] Ohgushi M, Sasai Y. Lonely death dance of human pluripotent stem cells: ROCKing between metastable cell states. Trends Cell Biol 2011; 21(5): 274-82.
[35] Earls JK, Jin S, Ye K. Mechanobiology of human pluripotent stem cells. Tissue Eng Part B Rev 2013; 19(5): 420-30.
[36] Watanabe K, Ueno M, Kamiya D, et al. A ROCK inhibitor permits survival of dissociated human embryonic stem cells. Nat Biotechnol 2007; 25(6): 681-6.
[37] Xu Y, Zhu X, Hahm HS, et al. Revealing a core signaling regulatory mechanism for pluripotent stem cell survival and self-renewal by small molecules. Proc Natl Acad Sci USA 2010; 107(18): 8129-34.
[38] Ulloa-Montoya F, Verfaillie CM, Hu W-S. Culture systems for pluripotent stem cells. J Biosci Bioeng 2005; 100(1): 12-27.
[39] James D, Levine AJ, Besser D, Hemmati-Brivanlou A. TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 2005; 132(6): 1273-82.
[40] Watabe T, Miyazono K. Roles of TGF-β family signaling in stem cell renewal and differentiation. Cell Res 2009; 19(1): 103-15.
[41] Turner DA, Trott J, Hayward P, Rue P. An interplay between extracellular signalling and the dynamics of the exit from pluripotency drives cell fate decisions in mouse ES cells. 2014; 614-26.
[42] Vallier L, Mendjan S, Brown S, et al. Activin/Nodal signalling maintains pluripotency by controlling Nanog expression. Development 2009; 136(8): 1339-49.
[43] Cheng D, Guo Y, Li Z, et al. Porcine induced pluripotent stem cells require LIF and maintain their developmental potential in early stage of embryos. PLoS One 2012; 7(12): e51778.
[44] Morikawa M, Koinuma D, Mizutani A, et al. BMP sustains embryonic stem cell self-renewal through distinct functions of different Krüppel-like factors. Stem Cell Reports 2016; 6(1): 64-73.
[45] Horiguchi I, Urabe Y, Kimura K, Sakai Y. Effects of glucose, lactate and basic FGF as limiting factors on the expansion of human induced pluripotent stem cells. J Biosci Bioeng 2018; 125(1): 111-5.
[46] Mulas C, Kalkan T, Smith A. NODAL secures pluripotency upon embryonic stem cell progression from the ground state. Stem Cell Reports 2017; 9(1): 77-91.
[47] Llames S, García-Pérez E, Meana Á, Larcher F, del Río M. Feeder layer cell actions and applications. Tissue Eng Part B Rev 2015; 21(4): 345-53.
[48] Tewary M, Shakiba N, Zandstra PW. Stem cell bioengineering: building from stem cell biology. Nat Rev Genet 2018; 19(10): 595-614.
[49] Eiselleova L, Peterkova I, Neradil J, Slaninova IVA, Hampl A, Dvorak P. Comparative study of mouse and human feeder cells for human embryonic stem cells. 2008; 363(January): 353-63.
[50] Xu R, Peck RM, Li DS, Feng X, Ludwig T, Thomson JA. Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. 2005; 2(3): 185-90.
[51] Cowling BJ, Freeman G, Wong JY, et al. Preliminary inferences on the age-specific seriousness of human disease caused by avian influenza A(H7N9) infections in China, March to April 2013. Euro Surveill 2013; 18(19): 20475.
[52] Abraham S, Sheridan SD, Miller B, Rao RR. Stable propagation of human embryonic and induced pluripotent stem cells on decellularized human substrates. Biotechnol Prog 2010; 26(4): 1126-34.
[53] Martin MJ, Muotri A, Gage F, Varki A. Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med 2005; 11(2): 228-32.
[54] Madl CM, Heilshorn SC, Blau HM. Bioengineering strategies to accelerate stem cell therapeutics. Nature 2018; 557(7705): 335-42.
[55] Unger C, Gao S, Cohen M, et al. Immortalized human skin fibroblast feeder cells support growth and maintenance of both human embryonic and induced pluripotent stem cells. Hum Reprod 2009; 24(10): 2567-81.
[56] Pekkanen-Mattila M, Ojala M, Kerkelä E, Rajala K, Skottman H, Aalto-Setälä K. The effect of human and mouse fibroblast feeder cells on cardiac differentiation of human pluripotent stem cells. Stem Cells Int 2012; 2012
[57] Sugii S, Kida Y, Berggren WT, et al. Feeder-dependent and feeder-independent iPS cell derivation from human and mouse adipose stem cells. Nat Protoc 2011; 6(3): 346-58.
[58] Hwang ST, Kang SW, Lee SJ, et al. The expansion of human ES and iPS cells on porous membranes and proliferating human adipose-derived feeder cells. Biomaterials 2010; 31(31): 8012-21.
[59] Chen Q, Qiu C, Huang Y, et al. Human amniotic epithelial cell feeder layers maintain iPS cell pluripotency by inhibiting endogenous DNA methyltransferase 1. Exp Ther Med 2013; 6(5): 1145-54.
[60] Liu T, Chen Q, Huang Y, Huang Q, Jiang L, Guo L. Low microRNA-199a expression in human amniotic epithelial cell feeder layers maintains human-induced pluripotent stem cell pluripotency via increased leukemia inhibitory factor expression. Acta Biochim Biophys Sin (Shanghai) 2012; 44(3): 197-206.
[61] Richards M, Tan S, Fong C-Y, Biswas A, Chan W-K, Bongso A. Comparative evaluation of various human feeders for prolonged undifferentiated growth of human embryonic stem cells. Stem Cells 2003; 21(5): 546-56.
[62] Richards M, Fong C-Y, Chan W-K, Wong P-C, Bongso A. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol 2002; 20(9): 933-6.
[63] Zhang K, Cai Z, Li Y, et al. Utilization of human amniotic mesenchymal cells as feeder layers to sustain propagation of human embryonic stem cells in the undifferentiated state. Cell Reprogram 2011; 13(4): 281-8.
[64] Takahashi K, Narita M, Yokura M, Ichisaka T, Yamanaka S. Human induced pluripotent stem cells on autologous feeders. PLoS One 2009; 4(12): e8067.
[65] Mallon BS, Park K-Y, Chen KG, Hamilton RS, McKay RDG. Toward xeno-free culture of human embryonic stem cells. Int J Biochem Cell Biol 2006; 38(7): 1063-75.
[66] Yamasaki S, Taguchi Y, Shimamoto A, Mukasa H, Tahara H, Okamoto T. Generation of human induced pluripotent stem (Ips) cells in serum- and feeder-free defined culture and TGF-Β1 regulation of pluripotency. PLoS One 2014; 9(1): e87151.
[67] Rodin S, Domogatskaya A, Ström S, et al. Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511. Nat Biotechnol 2010; 28(6): 611-5.
[68] Rodin S, Antonsson L, Hovatta O, Tryggvason K. Monolayer culturing and cloning of human pluripotent stem cells on laminin-521-based matrices under xeno-free and chemically defined conditions. Nat Protoc 2014; 9(10): 2354-68.
[69] Nakagawa M, Taniguchi Y, Senda S, et al. A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells. Sci Rep 2014; 4: 3594.
[70] Chen G, Gulbranson DR, Hou Z, et al. Chemically defined conditions for human iPSC derivation and culture. Nat Methods 2011; 8(5): 424-9.
[71] Chen VC, Couture SM, Ye J, et al. Scalable GMP compliant suspension culture system for human ES cells. Stem Cell Res (Amst) 2012; 8(3): 388-402.
[72] Singh H, Mok P, Balakrishnan T, Rahmat SNB, Zweigerdt R. Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res (Amst) 2010; 4(3): 165-79.
[73] Fan Y, Wu J, Ashok P, Hsiung M, Tzanakakis ES. Production of human pluripotent stem cell therapeutics under defined xeno-free conditions: progress and challenges. Stem Cell Rev 2015; 11(1): 96-109.
[74] Fluri DA, Tonge PD, Song H, et al. Derivation, expansion and differentiation of induced pluripotent stem cells in continuous suspension cultures. Nat Methods 2012; 9(5): 509-16.
[75] Zujur D, Kanke K, Lichtler AC, Hojo H, Chung UI, Ohba S. Three-dimensional system enabling the maintenance and directed differentiation of pluripotent stem cells under defined conditions. Sci Adv 2017; 3(5): e1602875.
[76] Kato Y, Kim MH, Kino-Oka M. Comparison of growth kinetics between static and dynamic cultures of human induced pluripotent stem cells. J Biosci Bioeng 2018; 125(6): 736-40.
[77] Lin H, Li Q, Lei Y. Three-dimensional tissues using human pluripotent stem cell spheroids as biofabrication building blocks. Biofabrication 2017; 9(2): 025007.
[78] Barron V, Lyons E, Stenson-Cox C, McHugh PE, Pandit A. Bioreactors for cardiovascular cell and tissue growth: a review. Ann Biomed Eng 2003; 31(9): 1017-30.
[79] Martin Y, Vermette P. Bioreactors for tissue mass culture: design, characterization, and recent advances. Biomaterials 2005; 26(35): 7481-503.
[80] Veraitch FS, Scott R, Wong JW, Lye GJ, Mason C. The impact of manual processing on the expansion and directed differentiation of embryonic stem cells. Biotechnol Bioeng 2008; 99(5): 1216-29.
[81] Cormier JT, zur Nieden NI, Rancourt DE, Kallos MS. Expansion of undifferentiated murine embryonic stem cells as aggregates in suspension culture bioreactors. Tissue Eng 2006; 12(11): 3233-45.
[82] Wilmes A, Rauch C, Carta G, et al. Towards optimisation of induced pluripotent cell culture: Extracellular acidification results in growth arrest of iPSC prior to nutrient exhaustion. Toxicol In Vitro 2017; 45(Pt 3): 445-54.
[83] Gupta P, Hourigan K, Jadhav S, Bellare J, Verma P. Effect of lactate and pH on mouse pluripotent stem cells: Importance of media analysis. Biochem Eng J 2017; 118: 25-33.
[84] Lees JG, Gardner DK, Harvey AJ. Pluripotent stem cell metabolism and mitochondria: Beyond ATP. Stem Cells Int 2017; 2017: 2874283.
[85] Otsuji TG, Bin J, Yoshimura A, et al. A 3D sphere culture system containing functional polymers for large-scale human pluripotent stem cell production. Stem Cell Reports 2014; 2(5): 734-45.
[86] Grayson WL, Zhao F, Bunnell B, Ma T. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun 2007; 358(3): 948-53.
[87] Ezashi T, Das P, Roberts RM. Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci USA 2005; 102(13): 4783-8.
[88] Yoshida Y, Takahashi K, Okita K, Ichisaka T, Yamanaka S. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 2009; 5(3): 237-41.
[89] Hazeltine LB, Selekman JA, Palecek SP. Engineering the human pluripotent stem cell microenvironment to direct cell fate. Biotechnol Adv 2013; 31(7): 1002-19.
[90] Soriano Felipe X, Guerrero Espejo A, Bonanad Boix S. Cloning and stem cells. Med Clin Barc 2004; 122(4): 150-4.
[91] Si-Tayeb K, Noto FK, Nagaoka M, et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010; 51(1): 297-305.
[92] Bauwens CL, Peerani R, Niebruegge S, et al. Control of human embryonic stem cell colony and aggregate size heterogeneity influences differentiation trajectories. Stem Cells 2008; 26(9): 2300-10.
[93] Toyoda T, Mae S, Tanaka H, et al. Cell aggregation optimizes the differentiation of human ESCs and iPSCs into pancreatic bud-like progenitor cells. Stem Cell Res Amst 2015; 14(2): 185-97.
[94] Hamazaki T, Oka M, Yamanaka S, Terada N. Aggregation of embryonic stem cells induces Nanog repression and primitive endoderm differentiation. J Cell Sci 2004; 117(Pt 23): 5681-6.
[95] Nath SC, Horie M, Nagamori E, Kino-Oka M. Size- and time-dependent growth properties of human induced pluripotent stem cells in the culture of single aggregate. J Biosci Bioeng 2017; 124(4): 469-75.
[96] Sachlos E, Auguste DT. Embryoid body morphology influences diffusive transport of inductive biochemicals: a strategy for stem cell differentiation. Biomaterials 2008; 29(34): 4471-80.
[97] Olmer R, Lange A, Selzer S, et al. Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. Tissue Eng Part C Methods 2012; 18(10): 772-84.
[98] King JA, Miller WM. Bioreactor development for stem cell expansion and controlled differentiation. Curr Opin Chem Biol 2007; 11(4): 394-8.
[99] Horiguchi I, Sakai Y. Serum replacement with albumin-associated lipids prevents excess aggregation and enhances growth of induced pluripotent stem cells in suspension culture. 2016; 1009-6.
[100] Fridley KM, Kinney MA, McDevitt TC. Hydrodynamic modulation of pluripotent stem cells. Stem Cell Res Ther 2012; 3(6): 45.
[101] Vining KH, Mooney DJ. Mechanical forces direct stem cell behaviour in development and regeneration. Nat Rev Mol Cell Biol 2017; 18(12): 728-42.
[102] Kehoe DE, Jing D, Lock LT, Tzanakakis ES, Ph D. Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng Part A 2010; 16(2): 405-21.
[103] Sargent CY, Berguig GY, Kinney MA, et al. Hydrodynamic modulation of embryonic stem cell differentiation by rotary orbital suspension culture. Biotechnol Bioeng 2010; 105(3): 611-26.
[104] Henzler H-J. Particle stress in bioreactors. Adv Biochem Eng Biotechnol 2000; 67: 35-82.
[105] dos Santos FF, Andrade PZ, da Silva CL, Cabral JMS. Bioreactor design for clinical-grade expansion of stem cells. Biotechnol J 2013; 8(6): 644-54.
[106] Archibald PRT, Chandra A, Thomas D, Chose O. Comparability of automated human induced pluripotent stem cell culture : a pilot study. 2016; 1847-58.
[107] Kikuchi T, Kino-Oka M, Wada M, et al. A novel, flexible and automated manufacturing facility for cell-based health care products: Tissue Factory. Regen Ther 2018; 9: 89-99.
[108] Daniszewski M, Crombie DE, Henderson R, et al. Automated Cell Culture Systems and Their Applications to Human Pluripotent Stem Cell Studies. SLAS Technol 2018; 23(4): 315-25.
[109] Felder RA, Ph D. A Review of Cell Culture Automation 2002.
[110] Soares FAC, Chandra A, Thomas RJ, Pedersen RA, Vallier L, Williams DJ. Investigating the feasibility of scale up and automation of human induced pluripotent stem cells cultured in aggregates in feeder free conditions. J Biotechnol 2014; 173(1): 53-8.
[111] Haupt S, Grützner J, Thier MC, et al. Automated selection and harvesting of pluripotent stem cell colonies. Biotechnol Appl Biochem 2012; 59(2): 77-87.
[112] Serra M, Brito C, Correia C, Alves PM. Process engineering of human pluripotent stem cells for clinical application. Trends Biotechnol 2012; 30(6): 350-9.
[113] Kwok CK, Ueda Y, Kadari A, et al. Scalable stirred suspension culture for the generation of billions of human induced pluripotent stem cells using single-use bioreactors. J Tissue Eng Regen Med 2018; 12(2): e1076-87.
[114] Abbasalizadeh S, Larijani MR, Samadian A, Baharvand H. Bioprocess development for mass production of size-controlled human pluripotent stem cell aggregates in stirred suspension bioreactor. Tissue Eng Part C Methods 2012; 18(11): 831-51.
[115] Kehoe DE, Jing D, Lock LT, Tzanakakis ES. Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng Part A 2010; 16(2): 405-21.
[116] Kshitiz PJ, Park J, Kim P, et al. Control of stem cell fate and function by engineering physical microenvironments. Integr Biol 2012; 4(9): 1008-18.
[117] Leung HW, Chen A, Choo ABH, Reuveny S, Oh SKW. Agitation can induce differentiation of human pluripotent stem cells in microcarrier cultures. Tissue Eng Part C Methods 2011; 17(2): 165-72.
[118] Chalmers JJ. Cells and bubbles in sparged bioreactors. Cytotechnology 1994; 15(1-3): 311-20.
[119] Bae YB, Jang HK, Shin TH, et al. Microfluidic assessment of mechanical cell damage by extensional stress. Lab Chip 2016; 16(1): 96-103.
[120] Fernandes-Platzgummer A, Diogo MM, Baptista RP, da Silva CL, Cabral JMS. Scale-up of mouse embryonic stem cell expansion in stirred bioreactors. Biotechnol Prog 2011; 27(5): 1421-32.
[121] Chisti Y. Animal-cell damage in sparged bioreactors. Trends Biotechnol 2000; 18(10): 420-32.
[122] Shafa M, Krawetz R, Zhang Y, et al. Impact of stirred suspension bioreactor culture on the differentiation of murine embryonic stem cells into cardiomyocytes. BMC Cell Biol 2011; 12(1): 53.
[123] Vosough M, Omidinia E, Kadivar M, et al. Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture. Stem Cells Dev 2013; 22(20): 2693-705.
[124] Shafa M, Krawetz R, Zhang Y, et al. Impact of stirred suspension bioreactor culture on the differentiation of murine embryonic stem cells into cardiomyocytes. BMC Cell Biol 2011; 12(1): 53.
[125] Carpenedo RL, Sargent CY, McDevitt TC. Rotary suspension culture enhances the efficiency, yield, and homogeneity of embryoid body differentiation. Stem Cells 2007; 25(9): 2224-34.
[126] Lei X, Deng Z, Zhang H, et al. Rotary suspension culture enhances mesendoderm differentiation of embryonic stem cells through modulation of Wnt/β-catenin pathway. Stem Cell Rev 2014; 10(4): 526-38.
[127] Sargent CY, Berguig GY, McDevitt TC. Cardiomyogenic differentiation of embryoid bodies is promoted by rotary orbital suspension culture. Tissue Eng Part A 2009; 15(2): 331-42.
[128] Warnock JN, Al-Rubeai M. Bioreactor systems for the production of biopharmaceuticals from animal cells. Biotechnol Appl Biochem 2006; 45(Pt 1): 1-12.
[129] Freyer N, Knöspel F, Strahl N, et al. Hepatic Differentiation of Human Induced Pluripotent Stem Cells in a Perfused Three-Dimensional Multicompartment Bioreactor. Biores Open Access 2016; 5(1): 235-48.
[130] Meier F, Freyer N, Brzeszczynska J, et al. Hepatic differentiation of human iPSCs in different 3D models: A comparative study. Int J Mol Med 2017; 40(6): 1759-71.
[131] Roberts I, Baila S, Rice RB, et al. Scale-up of human embryonic stem cell culture using a hollow fibre bioreactor. Biotechnol Lett 2012; 34(12): 2307-15.
[132] Dame MK, Varani J. Recombinant collagen for animal product-free dextran microcarriers. Vitr Cell Dev Biol - Anim 2009; 44(10): 407-14.
[133] Lock LT, Tzanakakis ES. Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. Tissue Eng Part A 2009; 15(8): 2051-63.
[134] Oh SKW, Chen AK, Mok Y, et al. Long-term microcarrier suspension cultures of human embryonic stem cells. Stem Cell Res (Amst) 2009; 2(3): 219-30.
[135] Park J-HH, Pérez RA, Jin G-ZZ, Choi S-JJ, Kim H-WW, Wall IB. Microcarriers designed for cell culture and tissue engineering of bone. Tissue Eng Part B Rev 2013; 19(2): 172-90.
[136] Li B, Wang X, Wang Y, et al. Past, present, and future of microcarrier-based tissue engineering. J Orthop Translat 2015; 3(2): 51-7.
[137] Fernandes AM, Marinho PAN, Sartore RC, et al. Successful scale-up of human embryonic stem cell production in a stirred microcarrier culture system. Braz J Med Biol Res 2009; 42(6): 515-22.
[138] Chen AKL, Chen X, Choo ABH, Reuveny S, Oh SKW. Critical microcarrier properties affecting the expansion of undifferentiated human embryonic stem cells. Stem Cell Res (Amst) 2011; 7(2): 97-111.
[139] Fan Y, Hsiung M, Cheng C, Tzanakakis ES. Facile engineering of xeno-free microcarriers for the scalable cultivation of human pluripotent stem cells in stirred suspension. Tissue Eng Part A 2014; 20(3-4): 588-99.
[140] Uludag H, De Vos P, Tresco PA. Technology of mammalian cell encapsulation. Adv Drug Deliv Rev 2000; 42(1-2): 29-64.
[141] Siti-Ismail N, Bishop AE, Polak JM, Mantalaris A. The benefit of human embryonic stem cell encapsulation for prolonged feeder-free maintenance. Biomaterials 2008; 29(29): 3946-52.
[142] Horiguchi I, Chowdhury MM, Sakai Y, Tabata Y. Proliferation, morphology, and pluripotency of mouse induced pluripotent stem cells in three different types of alginate beads for mass production. Biotechnol Prog 2014; 30(4): 896-904.
[143] Kerscher P, Turnbull IC, Hodge AJ, et al. Direct hydrogel encapsulation of pluripotent stem cells enables ontomimetic differentiation and growth of engineered human heart tissues. Biomaterials 2016; 83: 383-95.
[144] Gerecht S, Burdick JA, Ferreira LS, Townsend SA, Langer R, Vunjak-Novakovic G. Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci USA 2007; 104(27): 11298-303.
[145] Horiguchi I, Sakai Y. Alginate Encapsulation of Pluripotent Stem Cells Using a Co-axial Nozzle. J Vis Exp 2015; (101): e52835.
[146] Wilson JL, Najia MA, Saeed R, McDevitt TC. Alginate encapsulation parameters influence the differentiation of microencapsulated embryonic stem cell aggregates. Biotechnol Bioeng 2014; 111(3): 618-31.
[147] Oh SKW, Fong WJ, Teo Y, et al. High density cultures of embryonic stem cells. Biotechnol Bioeng 2005; 91(5): 523-33.
[148] Wang Y, Chou BK, Dowey S, He C, Gerecht S, Cheng L. Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions. Stem Cell Res (Amst) 2013; 11(3): 1103-16.
[149] Wang Y, Chou B-K, Dowey S, He C, Gerecht S, Cheng L. Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions. Stem Cell Res (Amst) 2013; 11(3): 1103-16.
[150] Yue XS, Fujishiro M, Nishioka C, et al. Feeder cells support the culture of induced pluripotent stem cells even after chemical fixation. PLoS One 2012; 7(3): e32707.
[151] Tamm C, Pijuan Galitó S, Annerén C. A comparative study of protocols for mouse embryonic stem cell culturing. PLoS One 2013; 8(12): e81156.
[152] Si-Tayeb K, Noto FK, Nagaoka M, et al. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 2010; 51(1): 297-305.
[153] Craft AM, Rockel JS, Nartiss Y, Kandel RA, Alman BA, Keller GM. Generation of articular chondrocytes from human pluripotent stem cells. Nat Biotechnol 2015; 33(6): 638-45.
[154] Chal J, Oginuma M, Al Tanoury Z, et al. Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy. Nat Biotechnol 2015; 33(9): 962-9.
[155] Longmire TA, Ikonomou L, Hawkins F, et al. Efficient derivation of purified lung and thyroid progenitors from embryonic stem cells. 2013; 10(4): 617-38.
[156] Ozeki N, Mogi M, Kawai R, et al. Mouse-induced pluripotent stem cells differentiate into odontoblast-like cells with induction of altered adhesive and migratory phenotype of integrin. PLoS One 2013; 8(11): e80026.
[157] Wang H, Xi Y, Zheng Y, Wang X, Cooney AJ. Generation of electrophysiologically functional cardiomyocytes from mouse induced pluripotent stem cells. Stem Cell Res (Amst) 2016; 16(2): 522-30.
[158] Konagaya S, Ando T, Yamauchi T, Suemori H, Iwata H. Long-term maintenance of human induced pluripotent stem cells by automated cell culture system. Sci Rep 2015; 5: 16647.
[159] Paull D, Sevilla A, Zhou H, et al. Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells. Nat Methods 2015; 12(9): 885-92.
[160] Hussain W, Moens N, Veraitch FS, Hernandez D, Mason C, Lye GJ. Reproducible culture and differentiation of mouse embryonic stem cells using an automated microwell platform. Biochem Eng J 2013; 77(100): 246-57.
[161] Thomas RJ, Anderson D, Chandra A, et al. Automated, scalable culture of human embryonic stem cells in feeder-free conditions. Biotechnol Bioeng 2009; 102(6): 1636-44.
[162] Koike H, Kubota K, Sekine K, et al. Establishment of automated culture system for murine induced pluripotent stem cells. 2012; 2-9.
[163] Chen VC, Couture LA. The suspension culture of undifferentiated human pluripotent stem cells using spinner flasks. Methods Mol Biol 2015; 1283: 13-21.
[164] Abecasis B, Aguiar T, Arnault É, et al. Expansion of 3D human induced pluripotent stem cell aggregates in bioreactors: Bioprocess intensification and scaling-up approaches. J Biotechnol 2017; 246: 81-93.
[165] Shafa M, Sjonnesen K, Yamashita A, et al. Expansion and long-term maintenance of induced pluripotent stem cells in stirred suspension bioreactors. J Tissue Eng Regen Med 2012; 6(6): 462-72.
[166] Teo A, Mantalaris A, Song K, Lim M. A novel perfused rotary bioreactor for cardiomyogenesis of embryonic stem cells. Biotechnol Lett 2014; 36(5): 947-60.
[167] Rungarunlert S, Klincumhom N, Pirity MK, Dinnyes A. Enhanced cardiac differentiation of mouse embryonic stem cells by use of the slow-turning , lateral vessel ( STLV ) bioreactor. 2011; 1565-73.
[168] Lam AT-L, Chen AK-L, Li J, Birch WR, Reuveny S, Oh SK-W. Conjoint propagation and differentiation of human embryonic stem cells to cardiomyocytes in a defined microcarrier spinner culture. Stem Cell Res Ther 2014; 5(5): 110.
[169] Olmer R, Engels L, Usman A, et al. Differentiation of Human Pluripotent Stem Cells into Functional Endothelial Cells in Scalable Suspension Culture. Stem Cell Reports 2018; 10(5): 1657-72.
[170] Hwang YS, Cho J, Tay F, et al. The use of murine embryonic stem cells, alginate encapsulation, and rotary microgravity bioreactor in bone tissue engineering. Biomaterials 2009; 30(4): 499-507.
[171] Come J, Nissan X, Aubry L, et al. Improvement of culture conditions of human embryoid bodies using a controlled perfused and dialyzed bioreactor system. 2008; 14(4)
[172] Knöspel F, Freyer N, Stecklum M, Gerlach JC, Zeilinger K. Periodic harvesting of embryonic stem cells from a hollow-fiber membrane based four-compartment bioreactor. Biotechnol Prog 2016; 32(1): 141-51.
[173] Amimoto N, Mizumoto H, Nakazawa K, Ijima H, Funatsu K, Kajiwara T. Hepatic differentiation of mouse embryonic stem cells and induced pluripotent stem cells during organoid formation in hollow fibers. Tissue Eng Part A 2011; 17(15-16): 2071-8.
[174] Fernandes AM, Fernandes TG, Diogo MM, da Silva CL, Henrique D, Cabral JMS. Mouse embryonic stem cell expansion in a microcarrier-based stirred culture system. J Biotechnol 2007; 132(2): 227-36.
[175] Badenes SM, Fernandes TG, Rodrigues CAV, Diogo MM, Cabral JMS. Scalable expansion of human-induced pluripotent stem cells in xeno-free microcarriers. Methods Mol Biol 2015; 1283: 23-9.
[176] Bardy J, Chen AK, Lim YM, et al. Microcarrier suspension cultures for high-density expansion and differentiation of human pluripotent stem cells to neural progenitor cells. Tissue Eng Part C Methods 2013; 19(2): 166-80.
[177] Lock LT, Tzanakakis ES. Expansion and differentiation of human embryonic stem cells to endoderm progeny in a microcarrier stirred-suspension culture. Tissue Eng Part A 2009; 15(8): 2051-63.
[178] Lu S-J, Kelley T, Feng Q, et al. 3D microcarrier system for efficient differentiation of human pluripotent stem cells into hematopoietic cells without feeders and serum [corrected]. Regen Med 2013; 8(4): 413-24.
[179] Park Y, Chen Y, Ordovas L, Verfaillie CM. Hepatic differentiation of human embryonic stem cells on microcarriers. J Biotechnol 2014; 174(1): 39-48.
[180] Ting S, Chen A, Reuveny S, Oh S. An intermittent rocking platform for integrated expansion and differentiation of human pluripotent stem cells to cardiomyocytes in suspended microcarrier cultures. Stem Cell Res (Amst) 2014; 13(2): 202-13.
[181] Lecina M, Ting S, Choo A, Reuveny S, Oh S. Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. Tissue Eng Part C Methods 2010; 16(6): 1609-19.
[182] Chayosumrit M, Tuch B, Sidhu K. Alginate microcapsule for propagation and directed differentiation of hESCs to definitive endoderm. Biomaterials 2010; 31(3): 505-14.
[183] Wang N, Adams G, Buttery L, Falcone FH, Stolnik S. Alginate encapsulation technology supports embryonic stem cells differentiation into insulin-producing cells. J Biotechnol 2009; 144(4): 304-12.